Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients

Inclusion Criteria: * Patient with refractory ascites who has had a minimum of 5 paracentesis in the last 3 months. * Patient with an estimated life expectancy of at least 6 months on the day of inclusion. * Patient with contraindication to the application of a TIPS or who has expressed a refusal of the procedure or a non-functional TIPS * Patient affiliated with or in receipt of social security * Informed and written consent signed by the patient. Exclusion Criteria: * Local or systemic infection in the month preceding the procedure * Hepatocellular carcinoma with palliative care * MELD Score \> 18 * Child Pugh C Score \> 10 * Creatinine Clearance \< 50 ml/mn * Digestive hemorrhage or episode of hepatic encephalopathy within two weeks prior to device insertion * Contraindication to general anesthesia * Contraindication to implant surgery of the device: * Obstructive urological impairment * Partitioning of ascites * Coagulopathy * Persons referred to in Articles L1121-5 to L1121-8 of the CSP (corresponding to all protected persons: pregnant woman, parturient, breastfeeding mother, person deprived of liberty by judicial or administrative decision, person subject to a legal protection measure). * Patient currently participating in other clinical research or who participated in a clinical trial within one month prior to inclusion.